Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exome-wide analysis reveals role of LRP1 and additional novel loci in cognition. | HGG Adv | 2023 | 37305557 | PubTator, text mining | PubMed |
| A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations. | Diagn Pathol | 2023 | 37303048 | PubTator, text mining | PubMed |
| Adenomyosis and Its Possible Malignancy: A Review of the Literature. | Diagnostics (Basel) | 2023 | 37296736 | PubTator, text mining | PubMed |
| Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile. | Front Oncol | 2023 | 37287928 | PubTator, text mining | PubMed |
| Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers. | Int J Mol Sci | 2023 | 37240216 | PubTator, text mining | PubMed |
| Protein Phosphatase 2A: Role in T Cells and Diseases. | J Immunol Res | 2023 | 37234102 | PubTator, text mining | PubMed |
| Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects. | Mar Drugs | 2023 | 37233501 | PubTator, text mining | PubMed |
| Uterine serous carcinoma: assessing association between genomics and patterns of metastasis. | Front Oncol | 2023 | 37228503 | PubTator, text mining | PubMed |
| Senotherapeutic peptide treatment reduces biological age and senescence burden in human skin models. | NPJ Aging | 2023 | 37217561 | PubTator, text mining | PubMed |
| CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation. | Sci Adv | 2023 | 37205756 | PubTator, text mining | PubMed |
| The Current Status and Future Perspectives of Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Endometrial Cancer. | Curr Issues Mol Biol | 2023 | 37185744 | PubTator, text mining | PubMed |
| Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality. | J Transl Med | 2023 | 37170215 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter. | Cell Death Discov | 2023 | 37156838 | PubTator, text mining | PubMed |
| RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression. | Nucleic Acids Res | 2023 | 37125639 | PubTator, text mining | PubMed |
| Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity. | Diabetes Metab J | 2023 | 37096418 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 37085135 | PubTator, text mining | PubMed |
| Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital. | Front Oncol | 2023 | 37064128 | PubTator, text mining | PubMed |
| Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack? | Cells | 2023 | 37048141 | PubTator, text mining | PubMed |
| The evolution of non-small cell lung cancer metastases in TRACERx. | Nature | 2023 | 37046095 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=9